OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement; Related Payments Of Up To ~$0.6 Million Will Bring Total Collaboration Commitment To Date To ~$1.5M
Signed contract amendment is part of an overall strategic priority collaboration in the fight against AMR using Unyvero A30 platform in LMICs
Next phase to cover full AMR assay and cartridge development, analytical